Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-induced apoptosis of metastatic skin carcinoma.

Claerhout S, Verschooten L, Van Kelst S, De Vos R, Proby C, Agostinis P, Garmyn M.

Int J Cancer. 2010 Dec 15;127(12):2790-803. doi: 10.1002/ijc.25300.

2.

Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.

Lockwood WW, Chari R, Coe BP, Thu KL, Garnis C, Malloff CA, Campbell J, Williams AC, Hwang D, Zhu CQ, Buys TP, Yee J, English JC, Macaulay C, Tsao MS, Gazdar AF, Minna JD, Lam S, Lam WL.

PLoS Med. 2010 Jul 27;7(7):e1000315. doi: 10.1371/journal.pmed.1000315.

3.

Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics.

Lindon JC, Nicholson JK.

Annu Rev Anal Chem (Palo Alto Calif). 2008;1:45-69. doi: 10.1146/annurev.anchem.1.031207.113026. Review.

PMID:
20636074
4.

Intralesional chemotherapy for nonmelanoma skin cancer: a practical review.

Kirby JS, Miller CJ.

J Am Acad Dermatol. 2010 Oct;63(4):689-702. doi: 10.1016/j.jaad.2009.09.048. Epub 2010 Jun 1. Review.

PMID:
20605654
5.

A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors.

Sica G, Yoshizawa A, Sima CS, Azzoli CG, Downey RJ, Rusch VW, Travis WD, Moreira AL.

Am J Surg Pathol. 2010 Aug;34(8):1155-62. doi: 10.1097/PAS.0b013e3181e4ee32.

PMID:
20551825
6.

FACADE: a fast and sensitive algorithm for the segmentation and calling of high resolution array CGH data.

Coe BP, Chari R, MacAulay C, Lam WL.

Nucleic Acids Res. 2010 Aug;38(15):e157. doi: 10.1093/nar/gkq548. Epub 2010 Jun 15.

7.

Basal cell carcinoma: what's new under the sun.

Dessinioti C, Antoniou C, Katsambas A, Stratigos AJ.

Photochem Photobiol. 2010 May-Jun;86(3):481-91. doi: 10.1111/j.1751-1097.2010.00735.x. Review.

PMID:
20550646
8.

Non-coding RNAs: Meet thy masters.

Costa FF.

Bioessays. 2010 Jul;32(7):599-608. doi: 10.1002/bies.200900112. Review.

PMID:
20544733
9.

SEURAT: visual analytics for the integrated analysis of microarray data.

Gribov A, Sill M, Lück S, Rücker F, Döhner K, Bullinger L, Benner A, Unwin A.

BMC Med Genomics. 2010 Jun 3;3:21. doi: 10.1186/1755-8794-3-21.

10.

Genetic variation in microRNA networks: the implications for cancer research.

Ryan BM, Robles AI, Harris CC.

Nat Rev Cancer. 2010 Jun;10(6):389-402. doi: 10.1038/nrc2867. Review. Erratum in: Nat Rev Cancer. 2010 Jul;10(7):523.

11.

An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer.

Chari R, Coe BP, Vucic EA, Lockwood WW, Lam WL.

BMC Syst Biol. 2010 May 17;4:67. doi: 10.1186/1752-0509-4-67.

12.

Transcriptional gene silencing through epigenetic changes mediated by non-coding RNAs.

Malecová B, Morris KV.

Curr Opin Mol Ther. 2010 Apr;12(2):214-22. Review.

13.

Whole methylome analysis by ultra-deep sequencing using two-base encoding.

Bormann Chung CA, Boyd VL, McKernan KJ, Fu Y, Monighetti C, Peckham HE, Barker M.

PLoS One. 2010 Feb 22;5(2):e9320. doi: 10.1371/journal.pone.0009320.

14.

Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer.

Chari R, Thu KL, Wilson IM, Lockwood WW, Lonergan KM, Coe BP, Malloff CA, Gazdar AF, Lam S, Garnis C, MacAulay CE, Alvarez CE, Lam WL.

Cancer Metastasis Rev. 2010 Mar;29(1):73-93. doi: 10.1007/s10555-010-9199-2. Review.

15.

Genomics Portals: integrative web-platform for mining genomics data.

Shinde K, Phatak M, Johannes FM, Chen J, Li Q, Vineet JK, Hu Z, Ghosh K, Meller J, Medvedovic M.

BMC Genomics. 2010 Jan 13;11:27. doi: 10.1186/1471-2164-11-27.

16.

Long noncoding RNAs, chromatin, and development.

Caley DP, Pink RC, Trujillano D, Carter DR.

ScientificWorldJournal. 2010 Jan 8;10:90-102. doi: 10.1100/tsw.2010.7. Review.

17.

Targeting ornithine decarboxylase for the prevention of nonmelanoma skin cancer in humans.

Elmets CA, Athar M.

Cancer Prev Res (Phila). 2010 Jan;3(1):8-11. doi: 10.1158/1940-6207.CAPR-09-0248. Review.

18.

Histologic subtype in NSCLC: does it matter?

Selvaggi G, Scagliotti GV.

Oncology (Williston Park). 2009 Nov 30;23(13):1133-40. Review.

19.
20.

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

Starczynowski DT, Kuchenbauer F, Argiropoulos B, Sung S, Morin R, Muranyi A, Hirst M, Hogge D, Marra M, Wells RA, Buckstein R, Lam W, Humphries RK, Karsan A.

Nat Med. 2010 Jan;16(1):49-58. doi: 10.1038/nm.2054. Epub 2009 Nov 8.

PMID:
19898489

Supplemental Content

Support Center